| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |